About Index Trending news
Lists
Pricing
Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals is a biotechnology company utilizing deuterium todevelop novel medical candidates.

Elsewhere

Contributors to this profile

Alexa global traffic share

12 Jun 2017
$30,000,000
Post-IPO debt

Concert Pharmaceuticals Announces $30 Million Venture Debt Financing from Hercules Capital

businesswire
+1
30 Apr 2008
$37,000,000
Venture capital (Series C)
Added by
30 Nov 2006
$48,500,000
Venture capital (Series B)
Added by

Concert Pharma Raises $48.5 Million

PE Hub
17 Jul 2006
$10,000,000
Venture capital (Series A)
Added by